Literature DB >> 22265945

Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein.

Michelle J Bauer1, Melina M Georgousakis, Therese Vu, Anna Henningham, Andreas Hofmann, Mandy Rettel, Louise M Hafner, Kadaba S Sriprakash, David J McMillan.   

Abstract

A major challenge for Streptococcus pyogenes vaccine development is the identification of epitopes that confer protection from infection by multiple S. pyogenes M-types. Here we have identified and characterised the distribution of common variant sequences from individual repeat units of the C-repeat region (CRR) of M-proteins representing 77 different M-types. Three polyvalent fusion vaccine candidates (SV1, SV2 and SV3) incorporating the most common variants were subsequently expressed and purified, and demonstrated to be alpha-helical by Circular Dichroism (CD), a secondary conformational characteristic of the CRR in the M-protein. Antibodies raised against each of these constructs recognise M-proteins that vary in their CRR, and bind to the surface of multiple S. pyogenes isolates. Antibodies raised against SV1, containing five variant sequences, also kill heterologous S. pyogenes isolates in in vitro bactericidal assays. Further structural characterisation of this construct demonstrated the conformation of SV1 was stable at different pHs, and thermal unfolding of SV1 is a reversible process. Our findings demonstrate that linkage of multiple variant sequences into a single recombinant construct overcomes the need to embed the variant sequences in foreign helix promoting flanking sequences for conformational stability, and demonstrates the viability of the polyvalent candidates as global S. pyogenes vaccine candidates. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22265945     DOI: 10.1016/j.vaccine.2011.12.115

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

Review 1.  Strategies in the development of vaccines to prevent infections with group A streptococcus.

Authors:  Michael F Good; Michael R Batzloff; Manisha Pandey
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

2.  A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development.

Authors:  Martina Sanderson-Smith; David M P De Oliveira; Julien Guglielmini; David J McMillan; Therese Vu; Jessica K Holien; Anna Henningham; Andrew C Steer; Debra E Bessen; James B Dale; Nigel Curtis; Bernard W Beall; Mark J Walker; Michael W Parker; Jonathan R Carapetis; Laurence Van Melderen; Kadaba S Sriprakash; Pierre R Smeesters
Journal:  J Infect Dis       Date:  2014-05-05       Impact factor: 5.226

3.  Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study.

Authors:  D J McMillan; P-A Drèze; T Vu; D E Bessen; J Guglielmini; A C Steer; J R Carapetis; L Van Melderen; K S Sriprakash; P R Smeesters
Journal:  Clin Microbiol Infect       Date:  2013-03-07       Impact factor: 8.067

Review 4.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 5.  Staphylococcal and streptococcal superantigen exotoxins.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Petra L Kohler; Alexander R Horswill; Donald Y M Leung; Patrick M Schlievert
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

6.  Antibacterial Activity of Rhodomyrtus tomentosa (Aiton) Hassk. Leaf Extract against Clinical Isolates of Streptococcus pyogenes.

Authors:  Surasak Limsuwan; Oliver Kayser; Supayang Piyawan Voravuthikunchai
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-02       Impact factor: 2.629

7.  Peptide-based subunit vaccine against hookworm infection.

Authors:  Mariusz Skwarczynski; Annette M Dougall; Makan Khoshnejad; Saranya Chandrudu; Mark S Pearson; Alex Loukas; Istvan Toth
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

8.  Predicting Promiscuous T Cell Epitopes for Designing a Vaccine Against Streptococcus pyogenes.

Authors:  Samira Ebrahimi; Hassan Mohabatkar; Mandana Behbahani
Journal:  Appl Biochem Biotechnol       Date:  2018-06-11       Impact factor: 2.926

9.  Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate.

Authors:  Celia McNeilly; Samantha Cosh; Therese Vu; Jemma Nichols; Anna Henningham; Andreas Hofmann; Anne Fane; Pierre R Smeesters; Catherine M Rush; Louise M Hafner; Natkuman Ketheesan; Kadaba S Sriprakash; David J McMillan
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

10.  Modification of the classical Lancefield assay of group A streptococcal killing to reduce inter-donor variation.

Authors:  Mark Reglinski; Nicola N Lynskey; Shiranee Sriskandan
Journal:  J Microbiol Methods       Date:  2016-03-24       Impact factor: 2.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.